Follow The Filings

RNST Renasant

Renasant earnings company data as of 5:00 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 0.94 — —
Rev — — —

Insider trades

Open-market buys and sales by RNST's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RNST insider trades
  • $70K bought by 1 insider
  • $3.7M sold by 8 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Edward Robinson McGraw Director
    Sale
    $1.5M 35,000 shares at $43.88 14% of stake
    Traded Aug 3 Filed Aug 3
  2. Connie L Engel Director
    Sale
    $51K 1,257 shares at $40.90 7.5% of stake
    Traded May 29 Filed Jun 9
  3. Albert J Dale III Director
    Sale
    $66K 1,650 shares at $39.80 4% of stake
    Traded May 19 Filed May 21
  4. C Mitchell Waycaster Executive Vice Chairman
    Sale
    $502K 12,704 shares at $39.50 6.5% of stake
    Traded May 14 Filed May 15
  5. Kelly Hutcheson EVP/Chief Accounting Officer
    Sale
    $52K 1,350 shares at $38.65 7.5% of stake
    Traded Mar 4 Filed Mar 5
  6. M Ray Cole Jr. SEVP and Executive Advisor
    Sale
    $813K 20,000 shares at $40.63
    Traded Feb 13 Filed Feb 13
  7. Mark Jeanfreau EVP/General Counsel
    Sale
    $227K 6,000 shares at $37.88 8.4% of stake
    Traded Feb 2 Filed Feb 3
  8. James C. Mabry IV CFO
    Sale
    $473K 12,500 shares at $37.83 11% of stake
    Traded Jan 30 Filed Feb 2
  9. Jonathan A Levy Director
    Buy
    $70K 2,000 shares at $34.79 +24% to stake
    Traded Nov 11, 2025 Filed Nov 12, 2025

Also filed in the last 12 months, not counted as buying or selling: 30 stock grants, 9 share withholdings for taxes, 7 sales back to the company, 2 gifts, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01
SCHEDULE 13G —
8-K 7.01,9.01
10-Q
8-K 2.02,7.01,9.01
10-K/A
8-K 7.01,9.01
SCHEDULE 13G —
10-Q
8-K 1.01,2.03,7.01,9.01
424B5
424B5
8-K 5.03,5.07,9.01
SCHEDULE 13G —
8-K 7.01,9.01
SCHEDULE 13G —
8-K 2.02,7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.